BUZZ-Dicerna Pharmaceuticals Inc: Promising animal trial data

Mon Jun 30, 2014 8:50am EDT

** Drug developer's shares up 13 pct at $21.35 premarket

** Company presents positive preclinical data on its experimental liver disease drug

** The animal trials showed that Dicerna's drug blocked a gene that is found in patients with a rare inherited liver disorder called PH1

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.